Over a month ago |
Earnings
|
The company said,… The company said, "We are adjusting our assumption for average office occupancy, which we now expect to be between 81% and 83% for the year. As a result, we adjusted our expected range of same property cash NOI growth to be between -1.5% and -0.5%, and for straight-line revenue to be between $1 million and $3 million. These adjustments are offset by the benefit of our stock repurchase so our guidance range for full year FFO per fully diluted share remains between $1.87 and $1.93. We expect Net Income Per Common Share - Diluted to be between $0.35 and $0.41. Our guidance does not include the impact of future property acquisitions or dispositions, stock sales or repurchases, financings, property damage insurance recoveries, impairment charges or other possible capital markets activities." ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 04/05/23 Piper Sandler
- Douglas Emmett upgraded to Overweight from Neutral at Piper Sandler
- 03/30/23 BMO Capital
- Douglas Emmett price target lowered to $12 from $14 at BMO Capital
- 03/29/23 BMO Capital
- Douglas Emmett price target lowered to $12 from $13 at BMO Capital
- 03/27/23 Evercore ISI
- Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
- 05/02/23
- Douglas Emmett reports Q1 FFO 47c, consensus 48c
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 03/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Earnings
|
"During the first… "During the first quarter, we signed 235 office leases covering approximately 625,000 square feet, including 168,000 square feet of new leases," the company said. "The slowdown in the leasing pipeline that we mentioned on our last call resulted in a decline in our leased rate, even though we actually signed more leases in the quarter than usual. We continue to have strong demand from tenants under 10,000 square feet, who dominate our markets. But because larger tenants have become more conservative in response to recessionary concerns, we leased less total square footage. Comparing the office leases we signed during the first quarter to the expiring leases for the same space, straight-line rents increased by 6.0% and cash rents decreased by 6.7%. Our multifamily portfolio remains essentially fully leased at 99.3%." ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 04/05/23 Piper Sandler
- Douglas Emmett upgraded to Overweight from Neutral at Piper Sandler
- 03/30/23 BMO Capital
- Douglas Emmett price target lowered to $12 from $14 at BMO Capital
- 03/29/23 BMO Capital
- Douglas Emmett price target lowered to $12 from $13 at BMO Capital
- 03/27/23 Evercore ISI
- Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- 03/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Upgrade
|
Piper Sandler analyst… Piper Sandler analyst Alexander Goldfarb upgraded Douglas Emmett to Overweight from Neutral with a price target of $15, up from $13. The company's implied cap rate of 11.5% and 70% discount to net asset value are "way too wide," the analyst tells investors in a research note. Douglas Emmett's core small tenants remain active, while its multifamily deliveries are exceeding pro forma, says the firm. ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 03/30/23 BMO Capital
- Douglas Emmett price target lowered to $12 from $14 at BMO Capital
- 03/29/23 BMO Capital
- Douglas Emmett price target lowered to $12 from $13 at BMO Capital
- 03/27/23 Evercore ISI
- Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
- 03/21/23 Piper Sandler
- Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- 03/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Recommendations
|
BMO Capital lowered the… BMO Capital lowered the firm's price target on Douglas Emmett to $12 from $14 and keeps an Underperform rating on the shares. The company has the land to more than double its multifamily portfolio in LA and Hawaii over time, but with the likely departure of its largest tenant, Warner Bros Discovery, in Burbank next year, the firm is reducing its 2024 occupancy assumptions and 2024 estimates, the analyst tells investors in a research note. The stock is inexpensive and risks of default are low, BMO adds, though cutting its FY24 FFO view by 5c to $1.77. ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 03/29/23 BMO Capital
- Douglas Emmett price target lowered to $12 from $13 at BMO Capital
- 03/27/23 Evercore ISI
- Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
- 03/21/23 Piper Sandler
- Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
- 03/03/23 BMO Capital
- Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- 03/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Recommendations
|
BMO Capital analyst John… BMO Capital analyst John Kim lowered the firm's price target on Douglas Emmett to $12 from $13 and keeps an Underperform rating on the shares after meeting with management. The firm believes the stock is "inexpensive" and risks of default are "low," but has reduced its 2024 occupancy assumptions and 2024 estimates, noting that 36% of Douglas Emmett's office leases are expiring in 2023-24. ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 03/27/23 Evercore ISI
- Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
- 03/21/23 Piper Sandler
- Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
- 03/03/23 BMO Capital
- Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
- 01/09/23 Credit Suisse
- Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- 03/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Recommendations
|
Evercore ISI analyst… Evercore ISI analyst Steve Sakwa lowered the firm's price target on Douglas Emmett to $16 from $17 and keeps an In Line rating on the shares. Based on Evercore's discussions with investors over the past few weeks, the number one question remains the health of the banking system and the availability of debt. REITs continue to have access to the unsecured bond market, but these institutions are not equipped to take back a significant amount of property, so "pretend and extend" may be "the name of the game," the firm says, adding that most lenders benefited from this method during the Great Financial Crisis. However, the office sector may be an area where this is not the case, as owners may not be willing to throw "good money" after bad as many face higher vacancy rates and cap ex requirements to re-tenant vacant space, Evercore ISI argues. Following the firm's NYC office tour conducted last week, Evercore has reduced its price targets across its office REIT stocks to reflect a more challenging leasing and lending environments. ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 03/21/23 Piper Sandler
- Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
- 03/03/23 BMO Capital
- Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
- 01/09/23 Credit Suisse
- Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
- 01/03/23 Jefferies
- Douglas Emmett downgraded at Jefferies on potential for worst case for offices
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- 03/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/27/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
Recommendations
|
Piper Sandler analyst… Piper Sandler analyst Alexander Goldfarb lowered the firm's price target on Douglas Emmett to $13 from $18 and keeps a Neutral rating on the shares. The analyst says fear is driving "depressed valuations" in the office real estate investment trust sector as debt and equity buyers have become adverse to new investment. Sponsorship once again has taken prominence for transactions, while the absence of private equity stepping forward despite what seems like active yields "emphasizes the uncertainty that now exists," the analyst tells investors in a research note. ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 03/03/23 BMO Capital
- Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
- 01/09/23 Credit Suisse
- Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
- 01/03/23 Jefferies
- Douglas Emmett downgraded at Jefferies on potential for worst case for offices
- 01/02/23 Jefferies
- Douglas Emmett downgraded to Underperform from Hold at Jefferies
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- 03/03/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/27/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
On The Fly
|
Want to get stock-moving… ShowHide Related Items >><< - 01/25/23
- Vornado, Rudin complete 350 Park Avenue, 40 East 52nd Street transactions
- 01/18/23
- Vornado cuts quarterly dividend to 37.5c per share
- 12/28/22
- Vornado falls 2% after exiting S&P500 index
- 12/28/22
- Vornado Realty Trust to replace RXO in the S&P MidCap 400 at open on January 5
- 11/09/22
- Trade Desk jumps 8% to $47.01 after Q3 results beat estimates
- 10/04/22
- Trade Desk sees long-term adjusted EBITDA at 40%
- 01/17/23
- TowneBank completes Farmers Bank merger
- 01/05/23
- TowneBank names Clark COO
- 12/16/22
- TowneBank expects to complete Farmers Bank merger in early January
- 11/23/22
- TowneBank announces retirement of president and COO Brad Schwartz
- 03/01/23
- Stellantis, Koc Holding strengthens Tofas JV, enhances partnership in Turkiye
- 02/28/23
- Stellantis announces $155M investment in three Indiana plants
- 02/28/23
- Stellantis announces $155M investment in three Indiana plants
- 02/27/23
- Stellantis taking 14.2% equity stake in McEwen Copper
- 02/08/23
- RadNet launches Enhanced Breast Cancer Detection service
- 12/19/22
- RadNet: DeepHealth receives FDA clearance for Saige-Density software
- 11/28/22
- RadNet's Aidence, Google Health enter collaboration for lung cancer screening
- 11/28/22
- RadNet subsidiary, Google Health announce agreement to license AI research model
- 01/12/23
- Porsche Cars North America reports 2022 U.S. retail deliveries of 70,065
- 12/16/22
- Volkswagen shareholders approve special dividend from Porsche IPO
- 11/28/22
- Hagerty opens Garage + Social Van Nuys, partners with Long , Emory
- 09/18/22
- Fly Intel: Top five weekend stock stories
- 02/14/23
- Nelson Peltz's Trian buys Disney, cuts Sysco in Q4
- 01/19/23
- Procter & Gamble says 'on track' to deliver FY23 guidance
- 01/19/23
- Procter & Gamble says Q2 growth broad based across business units
- 01/19/23
- Procter & Gamble reports Q2 gross margin down 160 bps vs. a year ago
- 02/01/23
- Itron expands collaboration with Smart Energy Water
- 01/10/23
- Itron to partner with Qatar District Cooling Company on energy operations
- 01/10/23
- Quantum names Kenneth Gianella as CFO, succeeding Mike Dodson
- 12/13/22
- Itron signs contract with GRU to modernize infrastructure
- 02/27/23
- GeoVax announces presentation of results from clinical study of HIV therapy
- 02/15/23
- GeoVax, EmVenio enters collaboration to expand Phase 2 COVID-19 booster trial
- 02/08/23
- GeoVax announces progress in establishing continuous cell line system
- 02/07/23
- GeoVax Labs expands Gedeptin clinical research
- 10/13/22
- Imara to combine with Enliven Therapeutics in all-stock transaction
- $305.27 /
+3.755 (+1.25%) - 02/23/23
- Domino's Pizza falls -10.2%
- 02/23/23
- Domino's Pizza sees FY23 CapEx $90M-$100M
- 02/23/23
- Domino's Pizza cuts two-to three-year outlook for global retail sales growth
- 12/15/22
- Domino's Pizza to enter Uruguay and Latvia
- 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- $10.77 /
-5.235 (-32.72%) - 03/03/23
- CareDx comments on MolDX publication of new billing, coding article
- 03/02/23
- CareDx trading resumes
- 03/02/23
- CareDx trading halted, volatility trading pause
- 02/16/23
- CareDx to present cellular transplant progress at Tandem Meetings
- 01/09/23
- Bilibili prices note repurchases, equity offering
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 11/29/22
- Bilibili jumps 11% to $13.95 after Q3 earnings beat and guidance
- $10.77 /
-5.235 (-32.72%) - 03/03/23 Craig-Hallum
- CareDx downgraded to Hold at Craig-Hallum after Medicare 'worst case scenario'
- 03/03/23 Craig-Hallum
- CareDx downgraded to Hold from Buy at Craig-Hallum
- 03/03/23 Raymond James
- CareDx double downgraded to Market Perform at Raymond James
- 03/03/23 Raymond James
- CareDx downgraded to Market Perform from Strong Buy at Raymond James
- 03/03/23 RBC Capital
- Stellantis upgraded to Outperform from Sector Perform at RBC Capital
- 02/24/23 RBC Capital
- Stellantis price target raised to EUR 19 from EUR 18 at RBC Capital
- 01/30/23 Berenberg
- Stellantis price target lowered to EUR 18 from EUR 19 at Berenberg
- 01/25/23 Morgan Stanley
- Stellantis price target lowered to EUR 18 from EUR 18.50 at Morgan Stanley
- 03/03/23 JPMorgan
- Procter & Gamble upgraded to Overweight from Neutral at JPMorgan
- 03/01/23 UBS
- Procter & Gamble upgraded to Buy from Neutral at UBS
- 02/16/23 Citi
- Citi launches beverage, personal space with six buys, two sells
- 02/16/23 Citi
- Procter & Gamble initiated with a Buy at Citi
- 03/03/23 Raymond James
- RadNet upgraded to Outperform on AI visibility at Raymond James
- 03/03/23 Raymond James
- RadNet upgraded to Outperform from Market Perform at Raymond James
- 09/29/22 Clarus
- Biogen's lecanemab could be positive revenue driver for Akumin, says Clarus
- 03/03/23 Citi
- Bilibili upgraded to Buy at Citi with growth seen picking up
- 03/03/23 Citi
- Bilibili upgraded to Buy from Neutral at Citi
- 12/13/22 Bernstein
- Bilibili raised to Market Perform at Bernstein with short case 'less compelling'
- 12/13/22 Bernstein
- Bilibili upgraded to Market Perform from Underperform at Bernstein
- 03/03/23 JPMorgan
- Itron downgraded to Underweight from Neutral at JPMorgan
- 02/28/23 Piper Sandler
- Itron price target raised to $58 from $48 at Piper Sandler
- 02/28/23 Baird
- Itron price target raised to $52 from $40 at Baird
- 02/02/23 TD Cowen
- Itron price target raised to $72 from $55 at Cowen
- $305.27 /
+3.755 (+1.25%) - 03/03/23
- Domino's Pizza downgraded at Gordon Haskett on lower long-term growth algorithm
- 03/03/23
- Domino's Pizza downgraded to Hold from Buy at Gordon Haskett
- 02/28/23 Stifel
- Domino's Pizza price target lowered to $300 from $320 at Stifel
- 02/28/23 Northcoast
- Domino's Pizza downgraded to Neutral from Buy at Northcoast
- 03/03/23 BMO Capital
- Vornado downgraded to Underperform from Market Perform at BMO Capital
- 01/04/23 Deutsche Bank
- Vornado price target lowered to $22 from $25 at Deutsche Bank
- 01/04/23 Mizuho
- Vornado upgraded to Neutral from Underperform at Mizuho
- 12/14/22 Citi
- Vornado downgraded to Sell from Neutral at Citi
- 03/03/23 BMO Capital
- Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
- 01/09/23 Credit Suisse
- Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
- 01/03/23 Jefferies
- Douglas Emmett downgraded at Jefferies on potential for worst case for offices
- 01/02/23 Jefferies
- Douglas Emmett downgraded to Underperform from Hold at Jefferies
- 03/03/23 HSBC
- Porsche downgraded to Hold from Buy at HSBC
- 01/30/23 Berenberg
- Porsche price target raised to EUR 120 from EUR 96.80 at Berenberg
- 01/25/23 Morgan Stanley
- Porsche price target raised to EUR 90 from EUR 82.50 at Morgan Stanley
- 01/11/23 Exane BNP Paribas
- Porsche downgraded to Neutral from Outperform at Exane BNP Paribas
- 03/03/23 BTIG
- Trade Desk initiated with a Neutral at BTIG
- 02/17/23 Citi
- Trade Desk price target raised to $76 from $60 at Citi
- 02/16/23 Morgan Stanley
- Trade Desk price target raised to $58 from $50 at Morgan Stanley
- 02/16/23 DA Davidson
- Trade Desk price target raised to $76 from $56 at DA Davidson
- 03/03/23 TD Cowen
- Enliven initiated with an Outperform at TD Cowen
- 03/03/23 Dawson James
- GeoVax Labs initiated with a Buy at Dawson James
- 10/26/22 H.C. Wainwright
- GeoVax Labs initiated with a Buy at H.C. Wainwright
- 05/23/22 Maxim
- Maxim sees GeoVax Labs undervalued, citing its MVA vaccine in monkeypox
- 03/03/23 Cantor Fitzgerald
- Nextracker initiated with an Overweight at Cantor Fitzgerald
- 03/03/23 Cantor Fitzgerald
- Nextracker initiated with an Overweight at Cantor Fitzgerald
- 03/03/23 Raymond James
- TowneBank resumed with an Outperform at Raymond James
- 03/03/23 Raymond James
- TowneBank initiated with an Outperform at Raymond James
- 02/17/23 Piper Sandler
- TowneBank resumed with an Overweight at Piper Sandler
- 02/13/23
- Vornado reports Q4 adjusted FFO 72c, consensus 67c
- 02/15/23
- Trade Desk sees Q1 revenue at least $363M, consensus $360.94M
- 02/15/23
- Trade Desk reports Q4 non-GAAP EPS 38c, consensus 36c
- 02/14/23
- Notable companies reporting before tomorrow's open
- 01/26/23
- TowneBank reports Q4 adjusted EPS 65c vs 55c last year
- 10/27/22
- TowneBank reports Q3 EPS 69c vs 69c last year
- 11/03/22
- Stellantis reports Q3 revenue EUR 42.1B vs. EUR 32.6B last year
- 02/28/23
- RadNet sees 2023 revenue $1.53B-$1.58B, consensus $1.46B
- 02/28/23
- RadNet reports Q4 adjusted EPS 11c, consensus 15c
- 11/09/22
- RadNet still sees 2022 revenue $1.36B-$1.41B, consensus $1.4B
- 11/09/22
- RadNet reports Q3 adjusted EPS 9c, consensus 16c
- 01/19/23
- Procter & Gamble raises FY23 sales growth outlook
- 01/19/23
- Procter & Gamble reports Q2 core EPS $1.59, consensus $1.59
- 01/18/23
- Notable companies reporting before tomorrow's open
- 02/27/23
- Itron sees FY23 EPS 70c-$1.10, consensus $1.53
- 02/27/23
- Itron sees Q1 EPS 5c-15c, consensus 21c
- 02/27/23
- Itron reports Q4 EPS 71c, vs 75c last year
- 11/03/22
- Itron sees Q4 EPS 0c- 15c, consensus 34c
- $305.27 /
+3.755 (+1.25%) - 02/23/23
- Domino's Pizza reports Q4 EPS $4.43, consensus $3.95
- 02/22/23
- Notable companies reporting before tomorrow's open
- 10/13/22
- Domino's Pizza reports Q3 EPS $2.79, consensus $2.97
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- $10.77 /
-5.235 (-32.72%) - 02/27/23
- CareDx sees FY23 revenue $328M-$338M, consensus $338.42M
- 02/27/23
- CareDx reports Q4 adjusted EPS (7c), consensus (9c)
- 01/09/23
- CareDx sees FY23 revenue $321.3M-$321.6M, consensus $347.69M
- 01/09/23
- CareDx reports preliminary Q4 revenue $81.9M-$82.2M, consensus $81.54M
- 03/02/23
- Bilibili reports Q4 EPS (48c), consensus (51c)
- 11/29/22
- Bilibili sees Q4 revenue RMB 6B-RMB 6.2B
- 11/29/22
- Bilibili reports Q3 adjusted EPS (63c), consensus (65c)
- 09/08/22
- Bilibili sees Q3 revenue RMB 5.6B - RMB 5.8B
|
Downgrade
|
BMO Capital downgraded… BMO Capital downgraded Douglas Emmett to Underperform from Market Perform with a price target of $13, down from $21. The company's leasing volumes remain elevated but offer no support to leased percent or occupancy where growth remains elusive, the analyst tells investors in a research note. In addition, interest rates remain a headwind and Douglas Emmett "will feel a stronger force" with an additional $437.4M of swaps expiring in 2023 following the $400M that expired in January, contends the firm. ShowHide Related Items >><< - 12/08/22
- Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c
- 12/08/22
- Douglas Emmett announces $300M share repurchase authorization
- 01/09/23 Credit Suisse
- Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
- 01/03/23 Jefferies
- Douglas Emmett downgraded at Jefferies on potential for worst case for offices
- 01/02/23 Jefferies
- Douglas Emmett downgraded to Underperform from Hold at Jefferies
- 10/07/22 Piper Sandler
- Douglas Emmett downgraded to Neutral from Overweight at Piper Sandler
- 02/07/23
- Douglas Emmett sees FY23 FFO $1.87-$1.93, consensus $1.97
- 02/07/23
- Douglas Emmett reports Q4 FFO 51c, consensus 52c
- 11/03/22
- Douglas Emmett narrows FY22 FFO view to $2.03-$2.05 from $2.03-$2.07
- 11/03/22
- Douglas Emmett reports Q3 FFO 51c, consensus 51c
- 09/27/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|